Jane Grogan - Nov 1, 2023 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Research
Signature
/s/ Wendell Taylor, attorney-in-fact for Dr. Grogan
Stock symbol
BIIB
Transactions as of
Nov 1, 2023
Transactions value $
$0
Form type
4
Date filed
11/3/2023, 05:06 PM
Previous filing
Oct 12, 2023
Next filing
Feb 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIIB Common Stock 0 Nov 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Award $0 +2.09K $0.00 2.09K Nov 1, 2023 Common Stock 2.09K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of November 1, 2023.